论文部分内容阅读
BACKGROUND: Highly selective cyclooxygenase-2 (COX-2) inhibitors have recently been approved for the treatment of colon cancer,breast cancer,urinary bladder cancer,and skin cancer. For the highly selective COX-2 celecoxib,the mechanism of action for inhib